Areas of Focus

Breast cancer is a complex disease with no simple solution. That's why our researchers are tackling it from every angle. Learn more about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Tumor Biology

Understanding the basic biology of breast cancer is allowing us to get to the very core of the disease. Every aspect, from a cancer cell’s genes to the tumor’s environment, is under investigation. Our researchers are exploring the molecules that make up a cancer cell, how and why it transitions from normal to abnormal and why tumors react differently to different treatments. Their efforts are giving us the knowledge to achieve both prevention and a cure.

Dr. Aaronson’s research is focused on discovery and functions of cancer genes. At the NCI as Chief, Laboratory of Cellular and Molecular Biology, he identified the first normal function of a cancer gene as that of a growth factor, PDGF, and cloned erbB2 (also...

Dr. Vandana Abramson is an Assistant Professor of Medicine in the division of hematology/oncology at Vanderbilt University. Dr. Abramson has extensive experience in the treatment of cancer patients and clinical trials. She has been actively involved in the design and...

Kathy S. Albain is Professor of Medicine (tenured) at Loyola University Chicago Stritch School of Medicine and is a Dean’s Senior Scholar. As a member of the Division of Hematology/Oncology, she devotes her clinical practice to patients with breast and lung cancer at...

Dr. Ambrosone is a Professor of Oncology and Chair of the Department of Cancer Prevention and Control at Roswell Park Cancer Institute. She is also co-leader of the CCSG Population Sciences Program. She was formerly a member of NCI’s EPIC Study Section and the...

Dr. Karen Anderson is a translational researcher at the Biodesign Institute at Arizona State University, with a joint appointment as a breast cancer medical oncologist at Mayo Clinic Arizona. Her research focuses on how the immune system can be harnessed to detect and...

Michael Andreeff received his MD and PhD from the University of Heidelberg, Germany, and additional training at Memorial Sloan Kettering Cancer Center. He has been a pioneer in flow cytometry since 1971, when he established the first flow cytometry laboratory at the...

Dr. Joaquin Arribas is the Director of Preclinical Research Program at Vall d’Hebron Institute of Oncology in Barcelona, Spain, where he leads a group focused on the study of growth factors, growth factor receptors, and the proteases involved in remodeling the...

Dr. Arteaga trained in Internal Medicine and Medical Oncology at Emory University and the UT Health Sciences Center San Antonio, respectively. He joined Vanderbilt in 1989 where he now holds the Donna S. Hall Chair in Breast Cancer Research and serves as Professor of...

Alan Ashworth, PhD, FR, is President of the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, a role he began in January 2015.  He was previously Chief Executive of the Institute of Cancer Research (ICR) in London, United Kingdom.In 1999 he...

The biological landscape is made up of a vast and dizzying number of variables that interact in complex and often seemingly random ways. The Atwal lab at Cold Spring Harbor Laboratory is applying principles from physics and computational sciences to understand the...

Dr. Bargonetti began at Hunter College as an Assistant Professor in 1994 and is currently a Full Professor and the Chair of the Molecular, Cellular and Developmental PhD Subprogram in Biology at the CUNY Graduate Center. Professor Bargonetti has carried out extensive...

Professor John Bartlett is Professor of Molecular Pathology at Edinburgh University, Fellow of the Royal College of Pathologists and the Group Leader of the Endocrine Cancer Group at the University of Edinburgh Cancer Research Centre at the Western General Hospital. Dr...

Dr. Baselga MD, PhD is the Physician-in-Chief of Memorial Sloan Kettering Cancer Center and has also been named as AACR President for 2015-2016. Dr. Baselga received his MD degree from the Universidad Autonoma of Barcelona in 1982. From 1996 to 2010, he was the...

Robert Benezra, PhD, is a Member at Memorial Sloan Kettering Cancer in the Department of Cell Biology and a Professor of Biology at Cornell Graduate School of Medical Sciences in New York City. As a postdoctoral fellow he identified the Id proteins as dominant negative...

Ross Berkowitz, MD is the William H. Baker Professor of Gynecology at Harvard Medical School and the Director of Gynecology and Gynecologic Oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital. In addition, he is also the Co-Director of the...

Dr. Bertagnolli is a Professor of Surgery at Harvard University Medical School, and an Associate Surgeon at Dana Farber Cancer Institute and Brigham and Women’s Hospital . She is presently the Chief of the Division of Surgical Oncology at Dana Farber/Brigham and...

Laura Biganzoli is the Director of the Breast Center at the Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. She earned her medical degree at the University of Pavia, Italy, and completed fellowships at the National Cancer Institute of Milan and at the Jules...

Dr. Bissell has been a visionary and pioneer in the area of the role of extracellular matrix (ECM) and microenvironment in regulation of tissue-specific gene expression with special emphasis in breast cancer, where she has changed a number of established paradigms. She...

Dr. Myles Brown is Director of the Center for Functional Cancer Epigenetics at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He obtained his BS in Biology from Yale and his MD from Johns Hopkins. Following training in internal...

Powel Brown is a medical oncologist and physician-scientist specializing in breast cancer treatment and prevention at the University of Texas, MD Anderson Cancer Center, where he is Chair of the Department of Clinical Cancer Prevention. He is conducting studies to...

Dr. Brugge is Co-Director of the Ludwig Center at Harvard Medical School. A graduate of Northwestern University, she did graduate work at the Baylor College of Medicine, completing her PhD in 1975, followed by postdoctoral training at the University of Colorado with Dr...

Lewis C. Cantley, PhD, is the Margaret and Herman Sokol Professor and Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/Ronald P. Stanton Clinical Cancer Program at New York Presbyterian Hospital. Dr. Cantley grew up in West...

Dr. Cardoso is the Director of the Breast Unit of the Champalimaud Cancer Clinical in Lisbon, Portugal. She earned her medical degree at the University of Porto in Portugal and completed fellowships in the Translational Research Unit of the Jules Bordet Institute (IJB...

Lisa A. Carey, MD is an experienced clinician-scientist, Division Chief of UNC Hematology/Oncology and Lineberger Comprehensive Cancer Center Associate Director for Clinical Research. She has developed and been PI of multiple clinical and translational trials and has a...

Darren Carpizo, MD, PhD, is a surgical oncologist specializing in the management of hepato-biliary and pancreatic cancers. Seventy-five percent of his time is devoted to laboratory research in the area of Developmental Therapeutics in both the basic and translational...

Dr. Chang obtained medical degree from Cambridge University, England and completed fellowship in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She was awarded research doctorate from the University of London. Breast cancer has been the...

Dr. Lewis A. Chodosh is a physician-scientist who received a BS in Molecular Biophysics and Biochemistry from Yale University, and MD from Harvard Medical School, and a PhD. in Biochemistry from M.I.T. in the laboratory of Dr. Phillip Sharp.  He performed his...

Michael Clarke, MD is a Professor of Medicine at Stanford University. He is the Karel and Avice Beekhuis Professor in Cancer Biology and Associate Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine. His interest is in Stem Cell Biology....

Dr. Elizabeth Comen is a medical oncologist at Memorial Sloan Kettering Cancer Center with a practice devoted to the study and treatment of patients with all stages of breast cancer. Dr. Comen earned her BA from Harvard College and her MD from Harvard Medical School....

A leader in international clinical trials research since 1977, Dr. Comis is known as a champion of patient access to cancer clinical trials, spearheading initiatives to raise awareness about the pivotal role of cancer clinical trials in cancer prevention, detection,...

Dr. Cortez graduated summa cum laude from the University of Illinois at Champaign-Urbana with Highest Honors in Biology and Biochemistry. He received his doctorate in 1997 in Molecular Cancer Biology from Duke University. After post-doctoral training as a Jane Coffin...

Fergus Couch is Professor and Chair of the Division of Experimental Pathology and Laboratory Medicine at the Mayo Clinic, with joint appointments in the Departments of Health Sciences Research and Biochemistry and Molecular Biology. Dr. Couch works on the genetics of...

Vincent Cryns, MD, is the Marian A. and Rodney P. Burgenske Chair in Diabetes Research and Chief, Division of Endocrinology, Diabetes & Metabolism at the University of Wisconsin School of Medicine and Public Health. He received his bachelor’s and medical...

Dr. Curtis is an Assistant Professor of Medicine and Genetics in the School of Medicine at Stanford University where she leads the Cancer Systems Biology Group and serves as Co-Director of the Molecular Tumor Board at the Stanford Cancer Institute. She received her...

Jack Cuzick is a Director of the Wolfson Institute of Preventive Medicine in London. He is also head of the Centre for Cancer Prevention and John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics and has previously worked...

Fifteen years ago, Alan D’Andrea began to study the molecular pathogenesis of Fanconi Anemia (FA), a human genetic disease characterized by bone marrow failure, cancer susceptibility, and cellular hypersensitivity to DNA crosslinking agents. Dr. D’Andrea...

William Dalton, MD, PhD, received his Bachelor of Science degree from Dartmouth College in 1997. He completed the MD-PhD training program at Emory University in 2010, where his research focused on the role of prolonged mitotic arrest in tumorigenesis and antimitotic...

Dr. Davidson is an experienced laboratory, translational, and clinical investigator. She has co-authored over 300 papers, reviews, and editorials in the peer review literature. She is President-elect of the American Association for Cancer Research (AACR), has served as...

Shelton Earp is the Lineberger Professor of Cancer Research, Director of UNC Cancer Care and former Director of the UNC Lineberger Comprehensive Cancer.  In these roles, he has helped develop basic, clinical and public health research and cancer care at one of the...

Originally from the United Kingdom, Matthew Ellis completed his medical training in the U.K. at the Universities of Cambridge and London.  After 11 years at Washington University in St Louis, Dr Ellis is the incoming Director of the Lester and Sue Smith Breast...

Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Biomedical Engineering and Electrical & Computer Engineering at the Georgia Institute of Technology. He is also appointed at Emory University...

Leisha Emens is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center. She received her MD-PhD from Baylor College of Medicine and completed her residency training in Internal Medicine at the University of Texas at Southwestern before...

Charis Eng, MD, PhD is the founding Chair of the Genomic Medicine Institute at the Cleveland Clinic, founding Director of the institute’s clinical component, the Center for Personalized Genetic Healthcare, and Professor and Vice Chairman of the Department of Genetics...

Dr. Esserman is a surgeon and breast cancer oncology specialist, and is the Director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco (UCSF).   In 1996, she started the Center of Excellence for Breast Cancer Care at...

Dr. Esteva received his MD and PhD degrees from the University of Zaragoza School of Medicine in his native Spain. He completed a residency in internal medicine at Cooper Hospital (Camden, NJ) and a fellowship in medical oncology at Georgetown University Medical Center...

Andrew J. Ewald earned his BS in physics from Haverford College and his PhD in biochemistry and molecular biophysics from the California Institute of Technology. He is currently an associate professor in the Departments of Cell Biology and Oncology at the Johns Hopkins...

Zhen Fan was awarded his medical degree in 1985 from the Medical School of Shanghai Medical University, one of China’s most prestigious medical schools, and completed additional graduate studies there in 1988. His medical residency and oncology research training were...

John Forbes is Professor of Surgical Oncology, University of Newcastle (Australia); Director, Department of Surgical Oncology, Calvary Mater Newcastle Hospital; and Director of Research, Australia and New Zealand Breast Cancer Trials Group. His breast cancer research...

Dr. Ford is a medical oncologist and geneticist at Stanford, devoted to studying the genetic basis of breast cancer development, treatment and prevention. He graduated from Yale where he received his MD in 1989. He trained clinically in Medicine and Oncology at...

Dr. Monica Fornier is an Associate Member at the Breast Medicine Service of Memorial Sloan Kettering Cancer Center and Assistant Professor at Weil Cornell Medical College. She specializes in the treatment of breast cancer. She is also an Assistant Professor at the...

Dr. Fuqua has a Bachelor's degree and a Master's Degree from the University of Houston. Her PhD is in Cancer Biology from the University of Texas Graduate School of Biomedical Science. She is a Professor of Medicine, and Molecular and Cellular Biology at Baylor College...

Judy E. Garber, MD, MPH is the Director of the Center for Cancer Genetics and Prevention at the Susan Smith Center for Women's Cancers at Dana-Farber Cancer Institute, Director of the Cancer Risk and Prevention Clinic at Brigham and Women’s Hospital, and...

Sharon Giordano is a Professor with tenure at The University of Texas MD Anderson Cancer Center in the Department of Breast Medical Oncology, Chair of the Department of Health Services Research, and Ad Interim Chair of Health Disparities Research.Dr. Giordano received...

William J. Gradishar is Betsy Bramsen Professor of Breast Oncology in the Division of Hematology and Medical Oncology at the Feinberg School Medicine at Northwestern University and a member of the Robert H. Lurie Comprehensive Cancer Center. He is Director of the...

Dr. Carrie R. Graveel earned her PhD. in Cellular and Molecular Biology from the University of Wisconsin-Madison in 2002. She then served as a postdoctoral fellow in the laboratory of Dr. George Vande Woude at Van Andel Research Institute (VARI) from 2002-2007. In 2007...

Mark I. Greene received his MD and PhD from the University of Manitoba in Canada, and the FRCP from the Royal College in 1976. In 1976 Dr. Greene moved from Canada to Harvard University. Professor Greene was appointed Assistant Professor at Harvard Medical School in...

Dr. Daniel Haber is Director of the MGH Cancer Center and the Isselbacher/Schwartz Professor of Oncology at Harvard Medical School. His laboratory interests have focused on the area of cancer genetics, including the etiology of the pediatric kidney cancer Wilms tumor...

Bruce G. Haffty, MD is Professor and Chairman, Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School and New Jersey Medical School and Associate Director, Rutgers Cancer Institute of New Jersey. His medical school training, internship, residency...

Dr. Han received a PhD in Microbial Genetics in Korea and did a postdoctoral fellowship at the University of Illinois at Chicago. After studying genetic mutations in the human genome, she became interested in cancer biology and began working in the Department of...

Adrian L. Harris, MD, DPhil is Professor of Medical Oncology at the University of Oxford and Director of the Cancer Research UK Medical Oncology Unit. He is a Consultant Medical Oncologist at the National Health Service, Oxford Radcliffe Hospital Trust, a NIHR...

Dr. Harris' research has focused on the development of biomarkers and targeted therapeutics to improve outcome for breast cancer patients. Her laboratory uses genomic technologies to develop breast cancer signatures that can be used to optimize selection for therapy....

Daniel Hayes, MD, is the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC) and the Stuart B. Padnos Professor of Breast Cancer Research. He received AB (1974) and MS (1977) degrees at Indiana University,...

Dr. Rachel Hazan received her PhD from George Washington University in 1990. She performed her thesis work under Dr. Joseph Schlessinger, where she studied Her2 signaling in breast cancer, and was the first to map Her2 phosphorylation sites. She then joined Dr. Gerald...

Dr. Hicks is a molecular geneticist using genomics to study the initiation and progression of cancer in human patients with the goal of developing clinical assays for improving the treatment of the disease.  His current studies expand on his previous work on the...

William Holloman, PhD has been a professor at the Weill Cornell Medical College for nearly thirty years. He studies genetic recombination, a molecular mechanism that moves genes around and also repairs DNA damage. This is an essential operation that cells use to...

Dr. Chi-Chen Hong is an Associate Member in the Department of Cancer Prevention and Control within the Division of Cancer Prevention and Population Sciences at Roswell Park. Dr. Hong's research is focused on breast cancer etiology, survivorship, and prognosis....

Kathryn B. Horwitz, PhD joined the faculty at the University of Colorado after undergraduate studies at Barnard College, graduate studies at the UT Southwestern Medical School and postdoctoral work at UT San Antonio. Research in her laboratory is both basic and...

Dr. Susan Band Horwitz is a Distinguished University Professor at the Albert Einstein College of Medicine. She grew up in Boston and after graduating from Bryn Mawr College, received her PhD in Biochemistry from Brandeis University.Dr. Horwitz has had a continuing...

Mien-Chie Hung, PhD is the Vice President for Basic Research, and Professor and Chair of the Department of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center and a basic scientist with a translational vision. Dr. Hung is a...

Dr. Stephen Hursting is Professor in the Department of Nutrition and the Lineberger Comprehensive Cancer Center at UNC-Chapel Hill and Professor at the UNC Nutrition Research Institute in Kannapolis, NC. He earned his PhD in nutritional biochemistry and MPH in...

Terry Hyslop is Professor of Biostatistics and Bioinformatics at Duke University and Director of Biostatistics for the Duke Cancer Institute. Dr. Hyslop has over 20 years of experience as a biostatistician, with methodological interests in the measurement of biomarkers...

Dr. Ince received his PhD in Pharmacology from Cornell and completed clinical training at Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School. Dr. Ince was a visiting clinical scientist at Massachusetts Institute of Technology,...

James N. Ingle, MD is Professor of Oncology and Foust Professor in Mayo Clinic College of Medicine. He is the leader of breast cancer research in the Mayo Clinic Comprehensive Cancer Center serving as Program Co-Leader of the Women's Cancer Program with...

Dr. Irie is Assistant Professor of Medicine and Oncological Sciences at the Tisch Cancer Institute and Dubin Breast Center of Icahn School of Medicine at Mount Sinai in New York City. She received her MD and PhD degrees from Harvard Medical School and completed a...

Darrell Irvine, PhD, is a Professor at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute. He also serves on the steering committee of the Ragon Institute of MGH, MIT and Harvard. His research is focused on the...

Dr. Jaffee is an internationally recognized expert in cancer immunology with specific expertise in the pre-clinical and early clinical development of immunotherapies for breast and pancreatic cancers. She has developed novel vaccine approaches for the treatment of...

Valerie Jansen, MD, PhD, received her undergraduate degree in chemistry from Maryville College and started her medical training at the University of Tennessee Health Science Center (UTHSC). She received her PhD degree from UTHSC in 2009, and her MD degree from the...

Dr. Joyce is Member in the Cancer Biology Program at Memorial Sloan Kettering Cancer Center (MSKCC) and a Professor of Cell Biology and Genentics at Weill Cornell University Graduate School of Medical Sciences. She received her doctorate in Biology from the University...

William G. Kaelin, Jr., MD obtained his undergraduate and MD degrees from Duke University and completed training in internal medicine at the Johns Hopkins Hospital, where he served as chief medical resident. He was a clinical fellow in medical oncology at the Dana-...

Yibin Kang is Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University. He graduated from Fudan University in Shanghai in 1995. After completing his graduate study at Duke in 2000, Dr. Kang became an Irvington Institute postdoctoral fellow with...

Benita Katzenellenbogen is Swanlund Professor of Physiology, Cell and Structural Biology, and director of a breast cancer research group at the University of Illinois at Urbana-Champaign. She is an internationally known endocrinologist and cancer researcher and has...

Thomas Kensler is Professor of Pharmacology & Chemical Biology at the University of Pittsburgh. He obtained his doctorate at MIT and trained as a postdoctoral fellow at the University of Wisconsin and at the National Cancer Institute. After 30 years on the faculty...

Dr. Annette R. Khaled joined the faculty of the University of Central Florida (UCF) College of Medicine (COM) after completing her pre-doctoral studies at the University of Florida and her post-doctoral studies at the National Cancer Institute (NCI). She is the...

Dr. Seema A. Khan is Professor of Surgery in the Feinberg School of Medicine at Northwestern University, and the Bluhm Family Professor of Cancer Research. She is the Co-leader of the Women’s Cancer Research Program at the Robert H. Lurie Comprehensive Cancer...

Mary-Claire King, PhD, is American Cancer Society Professor at the University of Washington, Seattle. She was the first to show that breast cancer is inherited in some families, as the result of mutations in the gene that she named BRCA1. In addition to inherited...

Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Deputy Director of Research Operations at the UC San Diego Moores Cancer Center. He received his MD and PhD. in Immunology from Harvard University and had his...

Deanna Kroetz, PhD, is Professor of Bioengineering in the School of Pharmacy at University of California, San Francisco. Since 2009, she has been a Member of UCSF’s Helen Diller Family Comprehensive Cancer Center. She serves as Member of the Scientific Advisory...

Dr. Kuhn is a scientist and entrepreneur with a career long commitment in personalized medicine and individualized cancer patient care. He is focused on the redesign of cancer care.Dr. Kuhn is a Professor at USC, a founding member of a new Institute of Convergent...

Dr. Charlotte Kuperwasser is the Director of the Raymond and Beverly Sackler Laboratory for the Convergence of Biomedical, Physical and Engineering Sciences at Tufts University School of Medicine. She is an Associate Professor Developmental, Molecular & Chemical...

Joshua LaBaer is one of the nation's foremost investigators in the rapidly expanding field of personalized medicine. Formerly director of the Harvard Institute of Proteomics (HIP), he was recruited to ASU's Biodesign Institute as the first Piper Chair in...

A major focus of Dr. de Lange's research is to isolate the protein components in human telomeres and understand their roles in the cell. Several years ago, this work yielded an unexpected breakthrough, when Dr. de Lange and a collaborator at the UNC showed that the...

Dr. Lee is Professor of Pharmacology and Chemical Biology, and Professor of Human Genetics at the University of Pittsburgh, and Director of the Women’s Cancer Research Center at the University of Pittsburgh Cancer Institute and Magee Women’s Research...

Eva YHP Lee is the Chancellor’s Professor in the Department of Biological Chemistry at the University of California, Irvine School of Medicine.In the late 1980’s, Dr. Lee reported the inactivation of the prototypic tumor suppressor gene, the retinoblastoma...

Dr. Lee trained in clinical immunology at University of California, San Francisco and hematology at Stanford University. He was a tenured faculty member at Stanford before joining City of Hope in 2011, where he is now the Billy and Audrey L. Wilder Endowed Professor in...

Dr. Levine is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. He serves as the co-director for the National Science Foundation sponsored Center for Theoretical Biological Physics (CTBP), located on the campus of...

Karen Liby earned her PhD from the University of Cincinnati and then worked with Michael B. Sporn, a pioneer in the field of chemoprevention, at Dartmouth Medical School for 12 years.  She recently started an Associate Professor position focused on drug discovery...

Dr. Rosette Lidereau received her PhD in oncology and immunology in 1987 from the Pasteur Institute (working with Chairman and Prof. Barret-Sinoussi) and completed a fellowship in the Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda (Prof...

Dr. Lin is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Assistant Professor of Medicine at Harvard Medical School. Dr. Lin received her medical degree at Harvard Medical School and subsequently completed her residency in Internal Medicine at Brigham...

Marc E. Lippman, MD, MACP FRCP is the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard School of Medicine, and was Chairman of the Department of Medicine from May 2007 to May 2012. He is currently Deputy Director of the Sylvester...

Dr. Livingston is a scientist/oncologist whose research has long been focused in the area of molecular cancer science. He received his AB cum laude from Harvard in 1961 and his MD magna cum laude from Tufts Medical School in 1965. He undertook his clinical training in...

Sherene Loi is a medical oncologist specializing in the treatment of breast cancer. She also leads a lab that focuses on genomics and novel therapeutics in breast cancer, particularly to understand the genomic and immune interface in breast cancer patients. Her...

Dr. Martens is Head of the laboratory of Breast Cancer Genomics and Proteomics at the department of Medical Oncology at Erasmus MC Cancer Institute, Rotterdam, Netherlands. Dr. Martens graduated (1988) and received his PhD (1994) in Molecular Biology at Wageningen...

Ursula A. Matulonis, MD, is Medical Director and Disease Center Leader of the Medical Gynecologic Oncology Program at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School.  Her research focuses on developing new targeted...

Dr. Hayley McDaid received her PhD from the Queens University of Belfast, where she characterized the role of the cAMP-dependent protein kinase A signaling pathway in breast and ovarian cancer. These studies pioneered her present-day  interest in targeted...

Dr. Sofia Merajver is a physician scientist with a translational focus on integrating molecular genetics of breast cancer with fundamental studies of the dynamics of cancer signal transduction into innovative clinical strategies for women at high risk for breast cancer...

Dr. Merghoub received his BA degree from University of Algiers, Algeria, and MS and PhD degrees with highest distinction from University of Paris, France. His thesis work focused on the study of genetic polymorphism in fetal hemoglobin gene in patients with sickle cell...

Kerstin Meyer obtained a BSc in biochemistry (Imperial College, London) in 1987, followed in 1990 by a PhD in molecular immunology (University of Cambridge). She continued to study aspects of immunoglobulin gene expression and diversity at the LMB, then the Gurdon...

Kathy D. Miller received her MD in 1991 from the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Miller completed internal medicine training at Hopkins, then returned to her native Midwest for fellowship training at Indiana University, serving as Chief Fellow in...

Gordon B. Mills, MD, PhD, was recruited to The University of Texas M. D. Anderson Cancer Center (MDACC) in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology, and serves as chairman of the...

Dr. Marsha A. Moses has had a long-standing interest in the biochemical and molecular mechanisms that underlie the regulation of breast tumor growth and progression. Dr. Moses and her laboratory have discovered a number of angiogenesis inhibitors, some of which are...

Dr. Mundi earned his MD from the SUNY Downstate Health Science Center in 2009. He completed residency training in internal medicine at Boston University in 2013 and subsequently began a fellowship in medical oncology and hematology at Columbia University. He first...

Dr. Muss is an experienced clinician-scientist, a Professor of Medicine at the University of North Carolina School of Medicine, and the Director of the Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. He has a major interest and...

Paul Nurse, who shared the 2001 Nobel Prize in Physiology or Medicine, was president of The Rockefeller University from 2003 to 2011.Dr. Nurse is noted for discoveries about molecular mechanisms that regulate the cell cycle, the process by which a cell copies its...

The main interest of Dr. Oesterreich’s research is to further our understanding of hormone action in women’s cancer in order to use this knowledge for improved diagnosis and endocrine treatment. Her studies have focused on breast cancer and in receptor action in...

Kenneth Offit is Chief of the Clinical Genetics Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC). He is also Professor of Medicine and Public Health at Weill Medical College of Cornell University, and Vice Chairman of the Program...

Dr. Olopade's research interests are diverse and include: 1) treatment of breast cancer, especially in young or pregnant women, 2) familial cancers; 3) molecular genetics of cancer; 4) cancer risk assessment and chemoprevention; 5) breast cancer and minority...

Dr. Osborne was born in St. Louis, Missouri and received his AB and his MD from the University of Missouri, both with honors. He completed his internship and residency at Johns Hopkins and followed this with three years as a Clinical Associate at the Medicine Branch of...

Dr. Clodia Osipo received her PhD in Molecular and Cellular Biochemistry from Loyola University in 2002 while working under Dr. Allen Frankfater. Thereafter, she did her post-doctoral fellowship at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School...

Michael O'Donnell, PhD is the Anthony and Judith Evnin Professor at The Rockefeller University. He studies the molecular machinery that replicates DNA and duplicates the cellular genome. Several years ago his laboratory made the first discovery of a protein that...

Pier Paolo Pandolfi received his MD and PhD from the University of Perugia, Italy. He received post-graduate training at the National Institute for Medical Research and the University of London in the UK. Dr. Pandolfi presently holds the Reisman Endowed Chair of...

Dr. Park is from Saginaw, MI and received his Bachelor’s degree from The University of Chicago in 1989. He then completed a dual MD-PhD training program at The University of Pennsylvania School of Medicine, graduating in 1995. After completing a residency in Internal...

Dr. Barbara Parker is involved in the studies of novel personalized therapies for the treatment of breast cancer, the impact of diet and lifestyle on breast cancer outcomes, and the quality of life of breast cancer survivors. She is the principal investigator for the...

Mark D. Pegram, MD is a renowned clinician and scholar in breast cancer research and a leader in translational medicine. Dr. Pegram played a major role in developing the drug Herceptin as a treatment for HER2-positive breast cancer, which constitutes about 20 percent...

Dr. Perou is a member of the Lineberger Comprehensive Cancer Center at UNC, and the Scientific Director of the UNC Bioinformatics Core. He received his PhD in Cellular and Molecular Biology from the Department of Pathology at the University of Utah (1996) where he...

Richard G. Pestell, MB, BS, MD, PhD, FACP, FRACP, MBA, is Special Advisor to Innovation, Thomas Jefferson University.  Until 2015, he served as Director, Kimmel Cancer Center; Vice President, Oncology Services; Associate Dean, Cancer Programs, and Chairman,...

Martine J. Piccart, MD, PhD, is Professor of Oncology at the Université Libre de Bruxelles (ULB), Belgium, and Director of Medicine at the Institut Jules Bordet.She is co-founder and chair of the Breast International Group (BIG), uniting 55 academic research groups...

Dr. Pierce completed residency in Radiation Oncology at Pennsylvania and was a senior investigator at the National Cancer Institute (NCI). She joined the Department of Radiation Oncology at Michigan in 1992, where she is currently Professor of Radiation Oncology and...

Kornelia Polyak, MD, PhD is a Professor of Medicine at Dana-Farber Cancer Institute, Harvard Medical School, and is an internationally recognized leader in the breast cancer field. Research in Dr. Polyak’s laboratory is dedicated to the molecular analysis of human...

Bruce Ponder is Emeritus Professor of Oncology at Cambridge, former Head of Oncology and Director of the Cancer Centre, and was the Founding Director of the Cancer Research UK Cambridge Research Institute. He established one of the first clinics for familial cancer and...

Elisa Port, MD, FACS joined Mount Sinai Hospital and its Icahn School of Medicine in 2010.  She serves as Chief of Breast Surgery and Director of the Dubin Breast Center. After receiving her medical degree from Mount Sinai in 1992, Dr. Port was a general surgery...

Dr. Peggy Porter, a pathologist and researcher, is a member of the Human Biology and Public Health Sciences Divisions at Fred Hutchinson Cancer Research Center and Professor of Pathology at the University of Washington. As head of the multi-institutional Women’s...

Simon Powell, MD, PhD is the Enid A. Haupt Professor and Chairman of the Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center. He is a member of the Molecular Biology Program of the Sloan-Kettering Institute, and Weill Cornell Graduate School of...

Dr. Press is a Professor in the Department of Pathology and holds the Harold E. Lee Chair in Cancer Research at the University of Southern California’s Norris Comprehensive Cancer Center. Dr. Press is a board certified pathologist, directs the USC Breast Cancer...

Dr Pusztai is Professor of Medicine at Yale University and Chief of the Breast Medical Oncology Section at the Yale Cancer Center. He is also Co-Director of the Cancer Center Genomics and Genetics Program. Dr. Pusztai received his medical degree from the Semmelweis...

Dr. Rae received a BS in biology from the University of Pittsburgh and PhD in pharmacology from Georgetown University. In graduate school he combined his interest in breast cancer research with cutting-edge aspects of pharmacology including personalized medicine which...

Gad Rennert has been chairman of the Carmel Medical Center Department of Community Medicine and Epidemiology since 1992. He is a professor and the head of the public health and epidemiology teaching group at the Technion Faculty of Medicine.Professor Rennert is also...

Dr. Andrea L. Richardson is an Associate Professor of Pathology and Director of the Pathology Community Practice Division at Johns Hopkins University School of Medicine, where she moved in 2015 after more than eight years on the faculty of Brigham and Women's Hospital...

Dr. David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine with a secondary appointment in Medicine (Oncology). He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and...

Mark Robson, MD, is an Associate Attending Physician of the Clinical Genetics and Breast Medicine Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center. He received his B.Sc. from Washington and Lee University and his MD from the University of...

Dr. Thomas Rohan is Chairman of the Department of Epidemiology and Population Health at the Albert Einstein College of Medicine in New York and Associate Director for Population Sciences in the Albert Einstein Cancer Center, and he recently completed a term as a member...

Neal Rosen, MD, PhD, is the Director of the Center for Mechanism-Based Therapeutics at Memorial Sloan Kettering Cancer Center and a Member in the Program in Molecular Pharmacology and Chemistry. His major interests include the study of the key molecular events and...

Hope S. Rugo, MD, is a Professor of Medicine in the Division of Hematology and Oncology at the University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, where she directs Breast Cancer and Clinical Trial Education. Her research interests...

Regina M. Santella, PhD, is a Professor of Environmental Health Sciences, and Director of the NIEHS Center for Environmental Health in Northern Manhattan. She is a laboratory-based biochemist with extensive experience in the area of chemical carcinogenesis and...

Dr. Schiff is Associate Professor at the Baylor College of Medicine, Sue & Lester Smith Breast Center and the Departments of Medicine and Molecular and Cellular Biology. She is an internationally recognized expert in breast cancer translational research and in...

Dr. Robert Schneider is the Albert Sabin Professor of Molecular Pathogenesis at NYU School of Medicine, an Associate Director of the NYU Cancer Institute, Breast Cancer Program Co-Director and Associate Dean for the Office of Therapeutics and Industry Alliances. He has...

Dr. Sharma is an Associate Professor in the Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She obtained her doctorate in Molecular Biology and Oncology from the University of Delhi. She then completed fellowships at both the...

Dr. Priyanka Sharma is an Associate Professor of Medicine at the University of Kansas Medical Center. She joined the department of Internal Medicine as a breast oncologist in 2005 after completing Internal Medicine residency, Chief Residency and Hematology-Oncology...

Dr. Lois Shepherd is a Professor in the Department of Pathology and Molecular Medicine at Queen's University. She completed her medical school training at McGill and spent three years in England where her interest in hematology developed. She completed her training as...

Dr. Slingerland received her MD from the University of Toronto in 1983, followed by a Fellowship in Internal Medicine with the Royal College of Physicians and Surgeons in Canada. In 1987, she was certified by the American Board in Internal Medicine and in Medical...

Dr. Christos Sotiriou earned a medical degree from the Université Libre de Bruxelles, Belgium, in 1993. He did his internal medicine/oncology residency at the Institut Jules Bordet and earned his specialty in this field in July 1999. From October 1999 through September...

Joseph Sparano is Professor of Medicine & Women's Health at the Albert Einstein College of Medicine, Associate Chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center, and Associate Director for Clinical Research at the Albert...

Michael B. Sporn received his MD degree at the University of Rochester, and then started a 35-year career at the National Institutes of Health, where he became the Chief of the Laboratory of Chemoprevention in the National Cancer Institute in 1978. In the 1980s his...

Sasha Stanton has an MD, PhD from the Albert Einstein College of Medicine in New York. She completed her residency in Internal Medicine at New York Hospital/Weill Cornell Medical Center and her Hematology Oncology Fellowship at the University of Washington/Fred...

Dr. Anna Maria Storniolo is a medical oncologist and Professor of Clinical Medicine at the Indiana University School of Medicine. She earned her medical degree at Stanford and completed her Internal Medicine residency and fellowships in Hematology and Medical Oncology...

The Translational Cancer Therapeutics (TCT) Laboratory is focused on identification of mechanisms of cancer evolution and its impact on drug resistance and patient stratification. Professor Swanton and his colleagues are using parallel clinical trial and integrative...

Dr. Szallasi received his Doctor of Medicine degree from the University of Medicine in Debrecen, Hungary, in 1988. He did postdoctoral research in molecular pharmacology of cancer at the National Cancer Institute. As a faculty member, first at the Uniformed Services...

Sohail Tavazoie graduated from the University of California at Berkeley and completed an MD-PhD program at Harvard-MIT, followed by residency training in Internal Medicine at Brigham & Women's Hospital at Harvard and medical oncology and postdoctoral fellowship...

Mary Beth Terry, PhD, is a Professor of Epidemiology at Columbia University’s Mailman School of Public Health. She focuses her research on breast cancer and in the molecular epidemiology and life-course methods of the disease, in particular. She is a cancer...

Dr. Thomspon’s core expertise is in cancer genomics. He was a project leader on the FDA-funded MAQCIII project. His was one of three laboratories world-wide to be designated as a primary sequencing lab for this international collaborative study. A member of the breast...

Dr. Ilan Tsarfaty received his BSc. (1983), MSc. (1986) and PhD (1990) from Tel Aviv University. From 1991-1994, he served as a postdoctoral research associate at the National Cancer Institute's Frederick Cancer Research and Development Center. He was a visiting...

Dr. George F. Vande Woude received his M.S. (1962) and PhD (1964) from Rutgers University. From 1964-1972, he served first as a postdoctoral research associate, then as a research virologist for the US Department of Agriculture at Plum Island Animal Disease Center. In...

Dr. van ’t Veer is a renowned molecular biologist, Principal Investigator of the Athena Breast Health Network at UCSF and Leader of the Breast Oncology Program in the Helen Diller Family Comprehensive Cancer Center. She is the former Head of Diagnostic Oncology at the...

Kala Visvanathan is an Associate Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health and the Department of Medical Oncology at Johns Hopkins School of Medicine. Dr. Visvanathan is Director the Clinical Cancer Genetics and...

Dr. Geoffrey M. Wahl is a Professor at the Salk Institute, an Adjunct Professor at the University of California, San Diego in the Department of Biology, and the past President of the American Association for Cancer Research (2006-2007). Dr. ...

Zhigang Charles Wang received his MD from Shanghai Second Medical University in Shanghai, China and his PhD in Microbiology and Immunology from New York Medical College. His resident training in pathology was completed at Rie-Jing Hospital in China and his post-...

Dr. Weinberg is a founding member of the Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research at the Massachusetts Institute of Technology (MIT). He is also the first Director of the Ludwig Cancer Center at MIT. He is an...

After completing his postdoctoral training at Washington University, Dr. Weiss was recruited to the University of Michigan in 1982 where he assumed the rank of Professor in 1988. In 1991, he was named as the first recipient of the Upjohn Professorship in Oncology, a...

Dr. Max S. Wicha founded the University of Michigan Comprehensive Cancer Center (UMCCC) in 1987 and served as director for 27 years. Under his direction the UMCCC has established itself as a national leader. He is a leader in breast cancer research and a pioneer in...

Cold Spring Harbor Laboratory scientist Michael Wigler, PhD, in collaboration with James Hicks, PhD, is analyzing the genomes of women with breast cancer in research aimed at eliminating "trial-and-error" approaches to therapy. This work is leading to...

Eric P. Winer, MD, is Professor of Medicine at Harvard Medical School and Chief, Division of Women's Cancers and the Thompson Senior Investigator in Breast Cancer Research at Dana-Farber Cancer Institute. He is also Co-Chair of the Breast Committee of the...

Antonio Wolff is a Professor of Oncology at the Johns Hopkins University School of Medicine, a member of the Breast and Ovarian Cancer Program at the Johns Hopkins Kimmel Comprehensive Cancer Center, and a breast cancer medical oncologist with expertise in clinical...

Norman Wolmark, MD is Chairman and Principal Investigator of the National Surgical Adjuvant Breast and Bowel Project (NSABP), which is primarily funded by the NCI and is based on the campus of Allegheny General Hospital in Pittsburgh, Pennsylvania. He is also Professor...

Dr. Gerburg Wulf is an Associate Professor of Medicine at Harvard Medical School and an Attending Physician in the Breast Oncology Group at Beth Israel Deaconess Medical Center (BIDMC) and the Dana-Farber Harvard Cancer Center (DFHCC).  She received her medical...

Dr. Xue earned his Bachelor of Science in chemistry from the University of Science and Technology of China in 2001. He completed his PhD in chemistry at Brown University in 2007, and later pursued a post-doctoral fellowship in medicinal chemistry at Northwestern...

Dr. Yu trained as a condensed matter theoretical physicist and has extensive experience in modeling of complex systems using techniques from statistical physics, Monte Carlo simulations, and molecular dynamics simulations. Dr. Yu uses modeling to explain and predict...

Dr. Zhang is an Assistant Professor at Lester and Sue Smith Breast Center of Baylor College of Medicine. He received his PhD degree from Columbia University under the mentorship of Dr. Lawrence Chasin where he focused on the biology of mRNA splicing.  He then...

Jean Zhao is Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Dana-Farber Cancer Institute (DFCI). Dr. Zhao’s research centers on understanding kinase signaling pathways in cancer. She has pioneered a new front in...